Thomas Schreck Named CEO Of Iken Tissue Therapeutics, Inc.

SAN FRANCISCO--(BUSINESS WIRE)--June 10, 2005--Thomas Schreck has been named Chief Executive Officer of Iken Tissue Therapeutics, Inc. Iken President Michael Siani-Rose presented Mr. Schreck to shareholders at the company's annual meeting on Thursday, June 9, 2005 in San Francisco. Mr. Schreck most recently served as Chief Financial Officer and Director of DURECT Corporation, an emerging specialty pharmaceutical company he co-founded in 1998.
"Tom Schreck's outstanding entrepreneurial strengths, leadership and financial skills were well demonstrated at DURECT," said Siani-Rose. "These are precisely the senior level skills Iken requires as we move into a deliberate, dynamic phase of development with Anginera(TM), our lead product," he said.